Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Heart Septal Defects D006343 2 associated lipids
Retinal Vein Occlusion D012170 2 associated lipids
Weil Disease D014895 2 associated lipids
Drowning D004332 2 associated lipids
Pulmonary Heart Disease D011660 2 associated lipids
Angina Pectoris, Variant D000788 3 associated lipids
Jejunal Diseases D007579 3 associated lipids
Pneumonia, Viral D011024 3 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Takayasu Arteritis D013625 3 associated lipids
Tachycardia, Supraventricular D013617 3 associated lipids
Pneumonia, Aspiration D011015 3 associated lipids
Infertility D007246 3 associated lipids
Contusions D003288 3 associated lipids
Macular Edema D008269 3 associated lipids
Hydatidiform Mole D006828 3 associated lipids
Yang Deficiency D016711 3 associated lipids
Aortic Rupture D001019 3 associated lipids
Hemorrhagic Fever with Renal Syndrome D006480 3 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
van Marwijk Kooy M et al. Filtration. A method to prepare white cell-poor platelet concentrates with optimal preservation of platelet viability. 1990 Transfusion pmid:2296787
Böck M et al. Storage of single-donor platelet concentrates: metabolic and functional changes. 1993 Transfusion pmid:8480351
Hansen TN and Brockbank KG Increased platelet aggregation due to chilling to 20 degrees C is not related to increased sensitivity to agonists. 1997 Transfusion pmid:9225932
van Prooijen HC et al. Differences in the susceptibility of platelets to freezing damage in relation to size. 1989 Jul-Aug Transfusion pmid:2526399
Stuart MJ The effect of irradiation on platelet arachidonic acid metabolism. 1983 Mar-Apr Transfusion pmid:6404019
Wallvik J et al. The effect of different agitation modes on platelet metabolism, thromboxane formation, and alpha-granular release during platelet storage. 1990 Transfusion pmid:2119532
Menitove JE et al. Use of PGE1 for preparation of platelet concentrates. 1986 Jul-Aug Transfusion pmid:2941906
Menitove JE et al. Use of prostacyclin to inhibit activation of platelets during preparation of platelet concentrates. 1984 Nov-Dec Transfusion pmid:6390814
Valeri CR et al. Circulation and hemostatic function of autologous fresh, liquid-preserved, and cryopreserved baboon platelets transfused to correct an aspirin-induced thrombocytopathy. 2002 Transfusion pmid:12430680
Boeri N et al. Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma. 1994 Transfusion pmid:7940660
Ohsaki S et al. Effect of prostaglandin E1 on graft function of kidneys from living related donors. 1992 Transpl. Int. pmid:14621746
Schütz A et al. Allogeneic heart transplantation following xenogeneic bridging. 1992 Transpl. Int. pmid:14621808
Yamada K et al. New morphological changes induced by FK506 in a short period in the rat kidney and the effect of superoxide dismutase and OKY-046 on THEM: the relationship of FK506 nephrotoxicity to lipid peroxidation and change in production of thromboxane A2 in the kidney. 1992 Transpl. Int. pmid:14621878
Mennander A et al. Chronic rejection of rat aortic allografts: effect of inhibition of the thromboxane cascade. 1992 Transpl. Int. pmid:14621882
Gianello P et al. Measurement of the vasoconstrictive substances endothelin, angiotensin II, and thromboxane B2 in cold storage solution can reveal previous renal ischemic insults. 1994 Transpl. Int. pmid:8117396
Torras J et al. Renal protective effect of liposomed superoxide dismutase in an experimental warm ischemia model. 1994 Transpl. Int. pmid:11271283
Yokoyama I et al. Liberation of vasoactive substances and its prevention with thromboxane A2 synthase inhibitor in pig liver transplantation. 1996 Transpl. Int. pmid:8748415
Schelzig H et al. Role of recombinant hirudin in a pig-to-human lung transplantation model. 2002 Transplant. Proc. pmid:12270449
Teraoka S et al. Multicenter trial of the therapeutic effect of a newly developed antiplatelet agent, satigrel, on biopsy-proven chronic rejection after kidney transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9122990
Ishine N et al. Hemodynamic analysis of post-reperfusion syndrome and the effect of preventing this syndrome using thromboxane A2 synthetase inhibitor (OKY-046) in swine liver transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123045
Suehiro T et al. Value of caval effluent in predicting early graft function after orthotopic liver transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123086
Yagi T et al. Hepatropic soluble vitamin E derivative EPC-K1 prevents warm ischemia/reperfusion injury of non-heart-beating donor liver transplantation in pigs. 1997 Feb-Mar Transplant. Proc. pmid:9123352
Hashimoto T et al. Experimental study on the relationship between prostaglandin production and acute pancreatic rejection. 1989 Transplant. Proc. pmid:2495617
Jorkasky DK et al. The effects of cyclosporine on human platelet aggregation and thromboxane release. 1989 Transplant. Proc. pmid:2705264
López-Boado MA et al. Free radical ablation prevents ischemic injury after long periods of cold storage in rat pancreas transplantation. 1990 Transplant. Proc. pmid:2219357
Alcaraz A et al. Experimental kidney transplantation in pigs from non-heart-beating donors: evaluation of vasoactive substances and renal artery flow. 2001 Transplant. Proc. pmid:11543815
Anderson CB et al. Thromboxane-B2 and renovascular resistance during hypothermic pulsatile perfusion. 1981 Transplant. Proc. pmid:7268892
Shimizu Y et al. Nafamostat mesilate prevents warm ischemia-reperfusion injury in canine pancreas autotransplantation. 1995 Transplant. Proc. pmid:8539906
Odor-Morales A et al. In vivo thromboxane production by different organs in the rat: its implication in organ transplant failure. 1987 Transplant. Proc. pmid:3617213
Kanji VK et al. Vitamin E suppresses cyclosporine A-induced increase in the urinary excretion of arachidonic acid metabolites including F2-isoprostanes in the rat model. 1999 Transplant. Proc. pmid:10331052
García-Valdecasas JC et al. Prostaglandin metabolism and hemodynamic alterations during human liver transplantation. 1993 Transplant. Proc. pmid:8470202
Uchiyama M et al. Comparison between nonpulsatile and pulsatile machine perfusion preservation in liver transplantation from non-heart-beating donors. 2001 Feb-Mar Transplant. Proc. pmid:11267136
Hoballah JJ et al. Lazaroid U74389G attenuates skeletal muscle reperfusion injury in a canine model. 1995 Transplant. Proc. pmid:7482936
Kasahara M et al. Effect of FK3311 on ischemia-reperfusion injury in canine pulmonary models. 2000 Transplant. Proc. pmid:11120230
Odor-Morales A et al. Increased thromboxane production by the pancreas after 24-hour preservation in UW-1 solution. 1991 Transplant. Proc. pmid:1989317
Kawai T et al. The changes in prostaglandins after segmental pancreatic transplantation. 1991 Transplant. Proc. pmid:1989318
Kin S et al. Effect of preservation on blood flow and production of prostacyclin and thromboxane A2 in canine segmental pancreatic autografts. 1991 Transplant. Proc. pmid:1989320
Quarto Di Palo F et al. Prevention of chronic cyclosporine nephrotoxicity in renal transplantation by picotamide. 1991 Transplant. Proc. pmid:1989347
Foegh ML et al. Thromboxane and inflammatory cell infiltration of the allograft of renal transplant patients. 1987 Transplant. Proc. pmid:3313875
Santillan-Doherty P et al. Urinary thromboxane B2 excretion during acute rejection in cyclosporine-treated experimental lung allotransplantation. 1992 Transplant. Proc. pmid:1412957
Norio K et al. Eicosanoids and delayed graft function in human renal transplantation. 2001 Transplant. Proc. pmid:11406239
Saumweber DM et al. The involvement of platelet-activating factor in hyperacute xenogeneic rejection and its modulation by the PAF-antagonist WEB 2086BS. 1991 Transplant. Proc. pmid:1990613
Su CL et al. Inducible cyclooxygenase expression mediating hypoxia/reoxygenation-induced pulmonary vasoconstriction is attenuated by a cyclooxygenase inhibitor in rats. 2012 Transplant. Proc. pmid:22564588
Pestana M et al. Kidney graft-infiltrating cells synthesize significantly higher amounts of prostaglandin E2 pre and during acute rejection. 1999 Feb-Mar Transplant. Proc. pmid:10083119
van den Dorpel MA et al. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients. 1999 Feb-Mar Transplant. Proc. pmid:10083130
WÅ‚odarczyk Z et al. Effects of pentoxifylline treatment on delayed graft function in cadaveric kidney recipients. 2000 Transplant. Proc. pmid:10995988
Schultze G et al. Effect of cyclosporine on the generation of prostanoids by cultured peripheral lymphocytes. 1984 Transplant. Proc. pmid:6592863
Nakache R et al. Pancreatic juice immunoreactive thromboxane B2 in pancreas allograft rejection. 1990 Transplant. Proc. pmid:1691546
Odor-Morales A et al. Urinary amylase, urinary insulin, or urinary thromboxane: which is the best predictor of pancreatic allograft rejection in the dog? 1990 Transplant. Proc. pmid:1691549
Urade M et al. Changes of thromboxane B2 level in experimental orthotopic liver transplantation in swines--the effect of warm ischemia and thromboxane A2 synthetase inhibition. 1992 Transplant. Proc. pmid:1496677
Oikawa K et al. Elimination of Kupffer cells suppresses activation of nuclear factor kappa B and production of cytokines and eicosanoids in non-heart-beating donors. 2001 Feb-Mar Transplant. Proc. pmid:11267090
Lim LK et al. Fine needle aspiration biopsy, serum beta 2-microglobulin, and urine thromboxane in renal allografts. 1989 Transplant. Proc. pmid:2669249
Odor-Morales A et al. Urinary thromboxane B2 as indicator of pancreatic allograft rejection in nonimmunosuppressed dogs. 1989 Transplant. Proc. pmid:2669272
Santillan-Doherty P et al. Thromboxane B2 and lung transplantation: correlation of rejection with levels detected in bronchoalveolar lavage. 1989 Transplant. Proc. pmid:2669273
Zhao Y et al. Feasibility of serial fine needle aspiration biopsies to monitor dog single lung allografts. 1989 Transplant. Proc. pmid:2669274
Foegh ML et al. Urine thromboxane as an immunologic monitor in kidney transplant patients. 1984 Transplant. Proc. pmid:6390872
Foegh ML et al. Monitoring of rat heart allograft rejection by urinary thromboxane. 1984 Transplant. Proc. pmid:6390873
Saumweber DM et al. Studies on xenograft rejection: the role of leukocytes and prostaglandins and their modulation by the hetrazepine WEB 2086BS. 1992 Transplant. Proc. pmid:1566436
Pratschke J et al. Allogeneic heart transplantation following xenografting. 1992 Transplant. Proc. pmid:1566482
Sinzinger H et al. Platelet-derived growth factor and prostacyclin in kidney transplant rejection. 1987 Transplant. Proc. pmid:3303560
Elzinga L et al. Fish oil vehicle for cyclosporine lowers renal thromboxanes and reduces experimental nephrotoxicity. 1987 Transplant. Proc. pmid:3824502
Anderson C et al. Thromboxane synthesis inhibition and renal allograft function. 1989 Transplant. Proc. pmid:2650085
Pepino P et al. LTC4, thromboxane B2 and 6-keto PGF1 in syngeneic and allogenic heterotopic cardiac transplant in rats. 1989 Transplant. Proc. pmid:2650170
Seelos R et al. Prostaglandin synthesis and survival after orthotopic liver transplantation in pigs. 1991 Transplant. Proc. pmid:1926413
Iyobe T et al. Changes in prostaglandin levels in experimental liver transplantation in rats. 1994 Transplant. Proc. pmid:8066723
Kagawa K et al. Prolongation of rat cardiac allograft survival with arachidonic acid metabolism inhibitor. 1987 Transplant. Proc. pmid:3103286
Colomer J et al. Thromboxane flux and urinary eicosanoids as an index of reperfusion injury in pancreas transplantation after different periods of cold storage. 1988 Transplant. Proc. pmid:3055474
Foegh ML et al. Differential effect of CGS 13080, a thromboxane synthase inhibitor, in suppressing serum and urine immunoreactive thromboxane B2 in kidney transplant patients. 1988 Transplant. Proc. pmid:3279631
Pittet JF et al. Protective effect of indomethacin in the development of the postreperfusion syndrome during liver transplantation in pigs. 1991 Transplant. Proc. pmid:1871874
Quereda C et al. Urinary thromboxane B2 and cyclic AMP in cyclosporine-A-treated kidney transplantation. 1994 Transplant. Proc. pmid:7940810
Fukuoka T et al. Platelet-activating factor as a vasodepressive mediator of liver ischemia. 1993 Transplant. Proc. pmid:8266523
Lim LK et al. Effect of the 5-lipoxygenase inhibitors EP 10045 and EP 10161 on cardiac graft cellular infiltrate and thromboxane formation. 1988 Transplant. Proc. pmid:3284052
Lim LK et al. Correlation of renal inflammatory cell infiltrate with thromboxane. 1988 Transplant. Proc. pmid:3284053
Häyry P et al. Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection. 1993 Transplant. Proc. pmid:8438433
Weir MR et al. Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans. 1990 Transplantation pmid:2301025
Nassiri M et al. Lymphoid organ production of immunomodulatory eicosanoids in mice resistant to neonatal tolerance induction. 1994 Transplantation pmid:8009599
Coffman TM et al. Effect of dietary fish oil supplementation on eicosanoid production by rat renal allografts. 1988 Transplantation pmid:3125638
Ogata K et al. Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospholipase A2 with LY329722. 2001 Transplantation pmid:11374398
Lane NJ et al. Inhibition of leukotriene B4 synthesis does not prevent development of acute renal failure following storage and transplantation. 1994 Transplantation pmid:7809921
Fan TP et al. Mechanism of action of cyclosporine in preventing cardiac allograft rejection. II. Graft tissue levels of prostacyclin and thromboxane. 1987 Transplantation pmid:3547787
Capitanio A et al. Detection of circulating released platelets after renal transplantation. 1982 Transplantation pmid:6461116
Gibbons CP et al. Cortical and vascular prostaglandin synthesis during renal allograft rejection in the rat. 1987 Transplantation pmid:3554639
Garvin PJ et al. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model. 1996 Transplantation pmid:8633364
Balkhy HH et al. Comparison of Eurocollins and University of Wisconsin solution in single flush preservation of the ischemic reperfused lung: an in vivo rabbit model. 1995 Transplantation pmid:7732552
Markewitz A et al. Reduction of cyclosporine-induced nephrotoxicity by cilastatin following clinical heart transplantation. 1994 Transplantation pmid:8154033
Khirabadi BS et al. Urine immunoreactive thromboxane B2 in rat cardiac allograft rejection. 1985 Transplantation pmid:3880966
Textor SC et al. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. 1993 Transplantation pmid:7685934
Petric R et al. Amelioration of experimental cyclosporine nephrotoxicity by calcium channel inhibition. 1992 Transplantation pmid:1465778
Johnson BF et al. Urinary thromboxane and 6-keto-prostaglandin F1 alpha are early markers of acute rejection in experimental pancreas transplantation. 1994 Transplantation pmid:7518618
Smith SR et al. Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity. 1993 Transplantation pmid:8279014
Proppe DG et al. Diagnostic value of urinary thromboxane B2 concentration in detection of initial acute rejection reactions in human renal allografts. 1995 Transplantation pmid:7709445
Youngelman DF et al. Effects of chronic cyclosporine administration on renal blood flow and intrarenal blood flow distribution. 1991 Transplantation pmid:1994546
Gladue RP and Newborg MF The protective effects of the thromboxane synthetase inhibitor Dazmegrel on nephrotoxicity in cyclosporine-treated rats. 1991 Transplantation pmid:1949170
Santillan-Doherty P et al. Urinary thromboxane B2 as an indicator of acute rejection in lung allotransplantation. 1988 Transplantation pmid:3285529
Post S et al. Rapid increase in the activity of enzymes of eicosanoid synthesis in hepatic and extrahepatic tissues after experimental liver transplantation. 1991 Transplantation pmid:1903222
García-Valdecasas JC et al. Prostacyclin, thromboxane, and oxygen free radicals and postoperative liver function in human liver transplantation. 1995 Transplantation pmid:7570973
Hotter G et al. Nitric oxide and arachidonate metabolism in ischemia-reperfusion associated with pancreas transplantation. 1995 Transplantation pmid:7871573
Schnabel FR et al. The relationship of urinary thromboxane excretion to cyclosporine nephrotoxicity. 1991 Transplantation pmid:2006526
Klassen DK et al. Effects of cyclosporine on human renal allograft renin and prostaglandin production. 1989 Transplantation pmid:2660347
Kawaguchi A et al. Increase in urinary thromboxane B2 in rats caused by cyclosporine. 1985 Transplantation pmid:4024243